Table 3 Life prolonging treatments and diagnostic tests during the last week of life
From: End-of-life care of patients with idiopathic pulmonary fibrosis
Place of death | ||||
|---|---|---|---|---|
Tertiary hospital | Community hospital | Home, nursing home or hospice | Total | |
Number of patients | 26 | 21 | 12 | 59 |
Life prolonging treatments (last 7 days) | ||||
NIV | 13 (50 %) | 4 (19 %)* | 0 | 17 (29 %) |
Parenteral fluids | 16 (62 %) | 11 (52 %) | 2 (16 %) | 29 (49 %) |
Antibiotics | 24 (92 %) | 13 (62 %)* | 2 (16 %) | 39 (66 %) |
Diagnostic tests (last 24 h) | ||||
X-rays | 8 (31 %) | 1 (5 %)* | 0 | 9 (15 %) |
Laboratory tests | 18 (69 %) | 7 (33 %)* | 0 | 25 (42 %) |